Prospective, double-blind, randomized study of safety and efficacy of abobotulinum A (AboBTXA) in women with interstitial cystitis/bladder pain syndrome (IC/BPS)

Trial Profile

Prospective, double-blind, randomized study of safety and efficacy of abobotulinum A (AboBTXA) in women with interstitial cystitis/bladder pain syndrome (IC/BPS)

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Nov 2015

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Interstitial cystitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top